Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01265329
Other study ID # 0810-C-051-MM
Secondary ID
Status Completed
Phase N/A
First received October 8, 2010
Last updated August 4, 2014
Start date October 2010
Est. completion date December 2012

Study information

Verified date August 2014
Source Instituto Valenciano de Infertilidad, IVI VALENCIA
Contact n/a
Is FDA regulated No
Health authority Spain: Ministry of Health
Study type Interventional

Clinical Trial Summary

In spite of the achievements and developement of the assisted reproduction techniques in the last years, there is still an elevated percentage of unsuccessful treatments, needing sometimes repeated attempts to reach pregnancy.

The molecular physiology of sperm is being better characterized, and some reports have demonstrated the implication of different molecular processes in the pathophysiology of male infertility.

Recently, different sperm selection methods have been based on these molecular differences, showing a better quality of the sperm population after selection.

The main objective of this research project is to clinically apply these techniques in order to increase the pregnancy rates per cycle in infertile couples attending assisted reproduction treatments.


Recruitment information / eligibility

Status Completed
Enrollment 237
Est. completion date December 2012
Est. primary completion date December 2012
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group 18 Years to 37 Years
Eligibility Inclusion Criteria:

MEN:

- >3million sperm after swimming process

WOMEN:

- < 37 YEARS OLD

- NO GYNECOLOGICAL ANOMOLIES

- HORMONAL VALUES WITHIN CLINICAL RANGE

Exclusion Criteria:

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Outcomes Assessor), Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Other:
Negative selection
Sperm selection to continue the treatment with healthy sperm

Locations

Country Name City State
Spain IVI Valencia Valencia

Sponsors (1)

Lead Sponsor Collaborator
Instituto Valenciano de Infertilidad, IVI VALENCIA

Country where clinical trial is conducted

Spain, 

Outcome

Type Measure Description Time frame Safety issue
Primary Gestation Sperm selection and blood sample confirming gestation 14 days No